PharmiWeb

MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy*

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

GSK's COPD treatment approved by Chinese regulators

Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled ...
Yahoo

FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...
Yahoo

7 Doctor-Backed COPD Treatments That Help You Breathe Easier (Hint: Tai Chi!)

Woman’s World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, having a cold or respiratory infection can temporarily make it harder ...
Hosted on MSN

Ohtuvayre: The First Novel COPD Treatment Approved in Over a Decade

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

Why do most people mistake COPD for asthma? Pulmonologist explains why that delay can be deadly

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need ...
The Pharma Letter

UK nod for Nucala for uncontrolled COPD of an eosinophilic phenotype for those on triple therapy

London-based drugmaker GSK has announced the UK approval of Nucala (mepolizumab) as an add-on maintenance biologic treatment ...
pharmaphorum

China clears GSK's Nucala for COPD

GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...
The American Journal of Managed Care

Assessing Patient-Reported Treatment Values in COPD

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management. Chronic obstructive ...
WebMD

What Are the Treatments for COPD?

Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...
European Medical Journal

COPD Treatment Withdrawal Raises Early Exacerbation Risk

New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...
WebMD

What Are the Treatments for COPD?

In addition, symptoms and effective treatments can change quite a bit as the disease gets worse, so it’s good to stay vigilant and check in with your doctor on a regular basis. Wherever you are on ...